Definitive Contract HHSO100201600027C

Award Date 8/17/16
Potential Completion Date 11/17/22
Potential Value $2.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Stillwater, MN 55082, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for clinical sample testing services in support of Zika virus vaccine evaluation and research. The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases awarded a $3,315,351.08 delivery order contract to Battelle Memorial Institute, a large nonprofit R&D organization, to provide these services. The contract does not have a set-aside designation. As the prime contractor, Battelle has subcontracted with several vendors...
This federal contract award to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, supports the development of a blood-screening assay for the detection of Zika virus RNA in plasma samples from whole blood donors. The $3,714,953.81 Cost Plus Fixed Fee contract with the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response has an ultimate completion date of August 21, 2024. Grifols Diagnostic Solutions Inc. has received...
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a cost-plus-fixed-fee definitive contract worth $7,735,010.61 to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the development of point-of-care and laboratory-based immunoassays for the presumptive diagnosis of Zika virus infection. This contract is not set aside. Inbios is a key partner to...
This federal contract award, valued at $492,835.60, was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Icon Government And Public Health Solutions, Inc., a foreign-owned for-profit organization. The award is a Delivery Order under the Medical Countermeasures Clinical Studies Network Indefinite Delivery Indefinite Quantity (IDIQ) contract and is for Zika biological sample collection tasks in support of clinical...
This $395,529.61 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization, for clinical sample testing services related to Zika virus vaccines. The contract is a delivery order under the Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases major program. It does...
This federal contract award to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, provides Anti-HCV (Ortho) EIA Kits under Purchase Order HHSN272201200352P. The $3,650.00 firm fixed-price award was made on April 2, 2012 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS). Diasorin Inc. is a subsidiary of Diasorin S.P.A., the parent company. Both entities have established a strong presence as...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Diasorin Inc., a foreign-owned, for-profit manufacturer of diagnostic testing equipment, assays, and reagents. The contract, valued at $794,162.20, is for patient care testing services. Diasorin Inc. is a subsidiary of the parent company Diasorin S.P.A. and has a proven track record as a federal contractor, providing chemiluminescence immunoassay analyzers,...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Diasorin Inc., a subsidiary of the foreign-owned, for-profit company Diasorin S.P.A. The $3,650.00 purchase order is for the supply of 480 test Anti-HCV (Hepatitis C) EIA kits. No set-aside designation was used for this acquisition. Diasorin is a major supplier of automated diagnostic testing equipment, assays, reagents, and...
This federal contract was awarded to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, by the Defense Health Agency. The $350,000 firm-fixed-price contract provides the agency with a range of diagnostic testing products and services, including analyzers, reagents, test kits, controls, and technical support. The contract was not set aside for a specific business category. Diasorin has a history of supporting federal healthcare programs through prime and subcontractor roles....
This federal contract award for $350,000 was issued by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of reagents and closely associated functions, with an ultimate completion date of September 30, 2017. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has a significant presence in the U.S....

The U.S. Department of Health and Human Services (HHS) awarded a $2,665,898 firm-fixed-price contract to Diasorin Inc., a foreign-owned, for-profit company, for the provision of automated immunoassays to detect Zika virus IgM and IgG antibodies. This contract is not associated with any set-aside designations.

As part of this effort, Diasorin has subcontracted with Boca Biolistics, LLC, a for-profit company, to provide characterized human blood specimens for use in the development of the Zika virus assays. Additionally, Health Research, Inc.'s Wadsworth Center Division, a non-profit organization, is serving as a subcontractor to provide plaque reduction neutralization testing results, access to human patient samples, and supporting diagnostic testing data to Diasorin. This contract supports Zika virus testing capabilities for federal healthcare operations.

Generated 4/2/25, 4:39 PM